Neumirna
Neumirna Therapeutics
Copenhagen, Denmark · $23.3M raised
- Headquarters
- Copenhagen
- Website
- neumirna.com
- Total Funding
- $23.3M
- Last Round
- $23.3M Series AJan 2025
- Rounds
- 1
About
Active investment
Summary
Neumirna is a Biotech company based in Copenhagen, Denmark. It has raised $23.3M in total across 1 round, most recently a $23.3M Series A round in Jan 2025. Investors include Angelini Ventures, Invivo Capital Partners and Innovestor.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neumirna"><img src="https://indexed.vc/api/badge/company/neumirna" alt="Neumirna on Indexed.vc" width="260" height="76" /></a>